scispace - formally typeset
Open AccessJournal Article

Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors.

Reads0
Chats0
TLDR
It is suggested that VEGF may be a positive factor in tumor angiogenesis in both human gliomas and meningiomas.
Abstract
To examine which growth factors correlate with neovascularization in human brain tumors, the mRNA levels of transforming growth factor α, transforming growth factor, β, basic fibroblast growth factor, and vascular endothelial growth factor (VEGF) genes were determined by a Northern blot analysis in surgically obtained human gliomas and meninglomas The vascular development was determined by counting the number of microvessels which were immunostained with von Willebrand factor We normalized the growth factor mRNA levels versus the glyceraldehyde phosphate dehydrogenase mRNA level In the 17 gliomas and 16 meningiomas examined, the mRNA of transforming growth factors α and β, basic fibroblast growth factor, and VEGF were expressed at various levels Among those 4 growth factors, the mRNA levels of VEGF, but not those of transforming growth factors α and β and basic fibroblast growth factor, correlated significantly with vascularity in both gliomas (correlation coefficient r = 0499; P < 005) and meningiomas (correlation coefficient r = 0779; P < 0001) These findings thus suggest that VEGF may be a positive factor in tumor angiogenesis in both human gliomas and meningiomas

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Angiogenesis in brain tumours

TL;DR: Emerging preclinical and clinical data indicate that anti-VEGF therapies are potentially effective in glioblastoma and can transiently normalize tumour vessels, creating a window of opportunity for optimally combining chemotherapeutics and radiation.
PatentDOI

Tyrosine kinase inhibitors

TL;DR: In this article, the imidazo[1,2-a]pyrimidine derivatives are used for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET.
Journal ArticleDOI

Vascular endothelial growth factor

TL;DR: The approaches to inhibittumor angiogenesis and edema formation in glioblastoma patients will concentrate on the disruption of VEGF/VEGF receptorsignal transduction pathway in vivo.
Journal ArticleDOI

Transforming Growth Factor-beta: Vasculogenesis, Angiogenesis, and Vessel Wall Integrity

TL;DR: Although the focus of this review will be on the endothelium, other vascular wall cells are also likely to be important in the pathogenesis of the vascular lesions revealed by genetic studies.
Related Papers (5)